Upcoming webinar: Patient and clinician involvement in the EU HTA regulation

May 31, 2024

Myeloma Patients Europe (MPE) and ALAN invite you to register to the webinar “Patient and clinician involvement in the EU Health Technology Assessment (HTA) regulation”

Date and time: Wednesday 26th June 2024, 15:00 – 16:30 CEST.

Link to register:


What can you expect ?

The webinar will be structured as a multistakeholder panel discussion on the EU HTA regulation and its impact concerning patient and clinician involvement.


• Anke-Peggy Holtorf, moderator, Steering Committee member and project coordinator for the Patient and Citizen Involvement in HTA Interest Group, Health Technology Assessment international (HTAi)

• François Houÿez, Treatment Information and Access Director / Health Policy Advisor, European Organisation for Rare Diseases (EURORDIS)

• Mihai Rotaru, Director Market Access, European Federation of Pharmaceutical Industries and Associations (EFPIA) • Mirjana Huic, HTA independent specialist in HTA/EBM Centre, Croatia

• Robin Doeswijk, Head of European Affairs, European Hematology Association (EHA)

• Representative of a payer organisation (TBC).

More information:

Registration to this event is free of charge. Feel free to forward the registration link to colleagues and other patient advocates who might be interested in attending the webinar. Should you be unable to attend the webinar, please feel free to send your questions in advance to info@mpeurope.org and we will make sure they reach our speaker. A recording of the webinar will be available shortly after the session. Keep an eye out for our social media profiles!

We look forward to your participation.